The TLR5 agonist fagellin extracted from bacterial flagella was shown to reduce GVHD and preserve long post-transplant immune reconstitution characterized by more Fop-3+ T regulator (T reg) cells (Hossain et al., 2011). The gene discussed is TLR5; the disease is graft versus host disease.